Cerivastatin
Baycol (cerivastatin) is a small molecule pharmaceutical. Cerivastatin was first approved as Baycol on 1997-06-26. It is used to treat coronary artery disease, hypercholesterolemia, hyperlipoproteinemias, and hypertriglyceridemia in the USA. The pharmaceutical is active against 3-hydroxy-3-methylglutaryl-Coenzyme A reductase.
| Trade Name | Baycol |
|---|---|
| Common Name | Cerivastatin |
| Indication | coronary artery disease, hypercholesterolemia, hyperlipoproteinemias, hypertriglyceridemia |
| Drug Class | Enzyme inhibitors: antihyperlipidemics (HMG-CoA inhibitors) |
